Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
GH Research ( (GHRS) ) has issued an announcement.
GH Research PLC announced its participation in the Stifel 2025 Healthcare Conference, which is set to occur in New York from November 11-13, 2025. The company plans to engage in a fireside chat and hold one-on-one investor meetings, highlighting its commitment to investor relations and industry engagement.
The most recent analyst rating on (GHRS) stock is a Buy with a $19.00 price target. To see the full list of analyst forecasts on GH Research stock, see the GHRS Stock Forecast page.
Spark’s Take on GHRS Stock
According to Spark, TipRanks’ AI Analyst, GHRS is a Neutral.
GH Research’s stock score reflects significant challenges in financial performance, with consistent losses and negative cash flows. The company’s strong equity base and low debt provide some stability. Technical indicators show some short-term momentum, but valuation concerns persist due to the negative P/E ratio and lack of profitability.
To see Spark’s full report on GHRS stock, click here.
More about GH Research
GH Research PLC operates in the healthcare industry, focusing on innovative treatments and therapies. The company is involved in developing novel solutions to address unmet medical needs, with a particular emphasis on advancing healthcare technologies.
Average Trading Volume: 278,309
Technical Sentiment Signal: Strong Buy
Current Market Cap: $843M
Find detailed analytics on GHRS stock on TipRanks’ Stock Analysis page.